These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2486541)

  • 1. Hyperlipidemia of nephrosis: pathophysiologic role in progressive glomerular disease.
    Diamond JR
    Am J Med; 1989 Nov; 87(5N):25N-29N. PubMed ID: 2486541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlipidemia and progressive renal disease.
    Keane WF; Mulcahy WS; Kasiske BL; Kim Y; O'Donnell MP
    Kidney Int Suppl; 1991 Apr; 31():S41-8. PubMed ID: 2046270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids and the progression of renal disease.
    Keane WF; O'Donnell MP; Kasiske BL; Schmitz PG
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S69-74. PubMed ID: 16989069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis.
    Diamond JR
    Kidney Int Suppl; 1991 Apr; 31():S29-34. PubMed ID: 2046267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered functional characteristics of rat macrophages during nephrosis. Synergistic effects of hypercholesterolemia.
    Diamond JR; Pesek I; McCarter MD; Karnovsky MJ
    Am J Pathol; 1989 Oct; 135(4):711-8. PubMed ID: 2801885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein glomerulopathy.
    Tsimihodimos V; Elisaf M
    Curr Opin Lipidol; 2011 Aug; 22(4):262-9. PubMed ID: 21464714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarities between glomerular sclerosis and atherosclerosis in human renal biopsy specimens: a role for lipoprotein glomerulopathy.
    Avram MM
    Am J Med; 1989 Nov; 87(5N):39N-41N. PubMed ID: 2486545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
    Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
    J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lipids on glomerular injury and progression of renal disease.
    Keane WF
    Verh K Acad Geneeskd Belg; 1994; 56(2):91-104. PubMed ID: 8048270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic implications of lipid-lowering agents in the progression of renal disease.
    Keane WF; Kasiske BL; O'Donnell MP; Schmitz PG
    Am J Med; 1989 Nov; 87(5N):21N-24N. PubMed ID: 2486540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in the sialoglycoprotein content of the glomerular basement membrane in experimental nephrosis.
    Quatacker J
    Acta Histochem Suppl; 1987; 34():107-8. PubMed ID: 3107051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats.
    Olson JL; Rennke HG; Venkatachalam MA
    Lab Invest; 1981 Mar; 44(3):271-9. PubMed ID: 7464051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular permselectivity in healthy and nephrotic humans.
    Scandling JD; Black VM; Deen WM; Myers BD
    Adv Nephrol Necker Hosp; 1992; 21():159-76. PubMed ID: 1566645
    [No Abstract]   [Full Text] [Related]  

  • 14. [Structure and function of the kidney glomerulus in experimental nephrosis].
    Herken H
    Nihon Ishikai Zasshi; 1966 Mar; 55(5):705-7. PubMed ID: 5951158
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of atherogenic lipoproteins in cytokine-mediated renovascular injury.
    Kirschenbaum MA; Pai R; Roh DD; Kamanna VS
    Miner Electrolyte Metab; 1996; 22(1-3):47-50. PubMed ID: 8676823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electron microscopic study on the glomerular vascular permeability in various experimental nephropathies].
    Aihara K
    Nihon Ika Daigaku Zasshi; 1967; 34(4):219-27. PubMed ID: 5582511
    [No Abstract]   [Full Text] [Related]  

  • 17. Addition of oleic acid to delipidated bovine serum albumin aggravates renal damage in experimental protein-overload nephrosis.
    van Timmeren MM; Bakker SJ; Stegeman CA; Gans RO; van Goor H
    Nephrol Dial Transplant; 2005 Nov; 20(11):2349-57. PubMed ID: 16144858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment.
    Stevenson FT; Kaysen GA
    Wien Klin Wochenschr; 1999 Apr; 111(8):307-14. PubMed ID: 10378311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of increased glomerular protein traffic in the progression of renal failure.
    Bruzzi I; Benigni A; Remuzzi G
    Kidney Int Suppl; 1997 Nov; 62():S29-31. PubMed ID: 9350674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does hyperlipidemia injure the kidney?
    Gröne EF; Gröne HJ
    Nat Clin Pract Nephrol; 2008 Aug; 4(8):424-5. PubMed ID: 18594500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.